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ABSTRACT

ARTICLE HISTORY

Dieulafoy lesions are tortuous vascular malformations characterized by thick walled submucosal arteries/large caliber arterioles protruding through a small mucosal defect surrounded
by normal mucosa. They can occur in the jejunum/ileum and can cause massive, lifethreatening GI bleeding. We present an 80-year-old female with three weeks of black tarry
stools, progressive dyspnea on exertion and generalized body weakness with no significant
findings on Esophagogastroduodenoscopy (EGD). Push enteroscopy revealed a Dieulafoy
lesion in the proximal jejunum and an overlying clot, with oozing of blood noted after clot
removal. The lesion was treated with Argon plasma coagulation (APC) and a post-APC fleshy
protuberance was clipped to secure hemostasis. It is therefore important to keep a high index
of suspicion for jejunal/ileal Dieulafoy lesions in patients with massive GI bleeding of unclear
etiology on EGD/colonoscopy.
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An 80-year-old female presented with three weeks of
black tarry stools, progressive dyspnea on exertion and
generalized body weakness. She denied hematemesis,
abdominal pain or recent Nonsteroidal anti-inflammatory drug (NSAID) use, and was up to date with colorectal cancer screening. Esophagogastroduodenoscopy
(EGD) showed no significant findings to explain her
severe anemia.
Push enteroscopy revealed a Dieulafoy lesion in
the proximal jejunum and an overlying clot, with
oozing of blood noted after clot removal (Figure 1).
The lesion was treated with Argon plasma coagulation (APC). There appeared to be a 5–6 mm fleshy

protuberance post-APC (Figure 2), which was
clipped (Figure 3), and hemostasis was achieved.
She was subsequently discharged from the hospital
with no complications.
Dieulafoy lesions are tortuous vascular malformations characterized by thick walled submucosal
arteries/large caliber arterioles protruding through
a small mucosal defect surrounded by normal
mucosa [1–4]. They are uncommon lesions and
contribute to 1–2% of acute Gastrointestinal (GI)
bleeds [3,5]. Dieulafoy lesions can occur throughout the GI tract- typically in the stomach (61 –
82%) and duodenum (15%), but may be seen in

Figure 1. Dieulafoy lesion in the proximal jejunum with
active bleeding.

Figure 2. Dieulafoy lesion in the proximal jejunum treated
with Argon plasma coagulation.
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Dieulafoy lesions can cause massive, lifethreatening GI bleeding. It is therefore important
to keep a high index of suspicion for jejunal/ileal
Dieulafoy lesions in patients with massive GI
bleeding of unclear etiology on EGD/colonoscopy.
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Figure 3. Dieulafoy lesion in the proximal jejunum followed
by clipping of 6 mm fleshy protuberance.

References

the jejunum or ileum (1%) [5]. Dieulafoy lesions
are more commonly seen in elderly males and
often associated with NSAID use causing mucosal
atrophy and ischemia. However, it may be seen in
females without NSAID use. Small mucosal defect
and intermittent bleeding can make it difficult to
diagnose Dieulafoy lesions but active bleeding may
be beneficial in identifying the lesion during EGD
[4]. Endoscopic management options include
banding, clipping, electrocautery, cyanoacrylate
glue, sclerotherapy, epinephrine injection, and
laser photocoagulation.

[1] Johnson A, Oger M, Capovilla M. Dieulafoy lesion of
the appendix. Digestive Liver Dis. 2014;46(9):e11.
[2] Thimmapuram J, Shah M, Srour J. Esophageal
Dieulafoy lesion: an unusual cause of GI bleeding.
Gastrointest Endosc. 2011;73(5):1055–1056.
[3] Baxter M, Aly EH. Dieulafoy’s lesion: current trends in
diagnosis and management. Ann R Coll Surg Engl.
2010;92(7):548–554.
[4] Kozan R, Gülen M, Yılmaz TU, et al. Massive lower
gastrointestinal bleeding from a jejunal Dieulafoy
lesion. Ulus Cerrahi Derg. 2014;30(4):225–227.
[5] Nojkov B, Cappell MS. Gastrointestinal bleeding from
Dieulafoy’s lesion: clinical presentation, endoscopic findings, and endoscopic therapy. World J Gastrointest Endosc.
2015;7(4):295–307.

